ASN Publications
@asnpublications.bsky.social
Showcasing the latest in kidney care, research, and innovation. Follow for updates from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.
Pinned
Did you know submitting original research to the ASN journals is as simple as uploading a Word document and answering a few questions? The system will automatically pull in the title, abstract, and author names into the submission form. Learn more: asnjournals.org/publish.
@rajmehrotra.bsky.social
@rajmehrotra.bsky.social
The Centers for Medicare & Medicaid Services removed race, ethnicity, and related
demographic fields from the End-stage Renal Disease Medical Evidence Report. Read about the implications of this policy change in #ASNJASN: kidney.pub/JASN1070
demographic fields from the End-stage Renal Disease Medical Evidence Report. Read about the implications of this policy change in #ASNJASN: kidney.pub/JASN1070
November 24, 2025 at 8:00 PM
The Centers for Medicare & Medicaid Services removed race, ethnicity, and related
demographic fields from the End-stage Renal Disease Medical Evidence Report. Read about the implications of this policy change in #ASNJASN: kidney.pub/JASN1070
demographic fields from the End-stage Renal Disease Medical Evidence Report. Read about the implications of this policy change in #ASNJASN: kidney.pub/JASN1070
Glomerular diseases are complex, but nephrology programs don't always have the faculty expertise and resources to provide training in that area. The Glomerular Disease Study and Trial Consortium (GlomCon) works to bridge the gap. Read more in #ASNCJASN kidney.pub/CJASN0891
November 24, 2025 at 6:00 PM
Glomerular diseases are complex, but nephrology programs don't always have the faculty expertise and resources to provide training in that area. The Glomerular Disease Study and Trial Consortium (GlomCon) works to bridge the gap. Read more in #ASNCJASN kidney.pub/CJASN0891
How can the nephrology community accelerate the adoption of life-saving treatments? Some drugs initially designed to treat diabetes have shown promise in preserving kidney function. Read more about ASN's new paradigm: saving kidneys, hearts, and lives. #ASNKidneyNews kidney.pub/KN1710-15
November 24, 2025 at 4:00 PM
How can the nephrology community accelerate the adoption of life-saving treatments? Some drugs initially designed to treat diabetes have shown promise in preserving kidney function. Read more about ASN's new paradigm: saving kidneys, hearts, and lives. #ASNKidneyNews kidney.pub/KN1710-15
Among hypertensive adults with ambulatory AKI, this #ASNCJASN study found plasma biomarkers reflecting impaired kidney tubule health measured at the time of ambulatory AKI are associated with subsequent non-recovery in kidney function. Read more: kidney.pub/CJASN0910
November 23, 2025 at 8:00 PM
Among hypertensive adults with ambulatory AKI, this #ASNCJASN study found plasma biomarkers reflecting impaired kidney tubule health measured at the time of ambulatory AKI are associated with subsequent non-recovery in kidney function. Read more: kidney.pub/CJASN0910
A new study reports that donor-derived cell-free DNA may provide a useful noninvasive marker of rejection in pediatric kidney allograft recipients. Read more about the findings in #ASNKidneyNews: kidney.pub/KN1710-22
November 23, 2025 at 4:00 PM
A new study reports that donor-derived cell-free DNA may provide a useful noninvasive marker of rejection in pediatric kidney allograft recipients. Read more about the findings in #ASNKidneyNews: kidney.pub/KN1710-22
A new risk prediction model for kidney transplant recipients can improve post-transplant care by identifying those at high risk of graft failure, allowing for personalized interventions. Read more in #ASNCJASN: kidney.pub/CJASN0883
November 22, 2025 at 8:00 PM
A new risk prediction model for kidney transplant recipients can improve post-transplant care by identifying those at high risk of graft failure, allowing for personalized interventions. Read more in #ASNCJASN: kidney.pub/CJASN0883
N-of-1 trials are single-patient randomized trials that systematically compare treatments in a repeated crossover fashion. Read more in this #ASNJASN Designing Clinical Trials article:
kidney.pub/JASN0906
kidney.pub/JASN0906
November 22, 2025 at 6:00 PM
N-of-1 trials are single-patient randomized trials that systematically compare treatments in a repeated crossover fashion. Read more in this #ASNJASN Designing Clinical Trials article:
kidney.pub/JASN0906
kidney.pub/JASN0906
New #ASNJASN podcast alert! Drs. Anna Zemke and Nisha Bansal discuss their study, “Accuracy of Identification of Cardiovascular Events with International Classification of Diseases Diagnosis Codes versus Physician Adjudication in CKD and Kidney Failure.” Listen here: kidney.pub/JPOD0874
November 21, 2025 at 7:00 PM
New #ASNJASN podcast alert! Drs. Anna Zemke and Nisha Bansal discuss their study, “Accuracy of Identification of Cardiovascular Events with International Classification of Diseases Diagnosis Codes versus Physician Adjudication in CKD and Kidney Failure.” Listen here: kidney.pub/JPOD0874
African Americans face high rates of diabetic kidney disease (DKD), and early detection is crucial to prevent severe kidney damage. This #ASNKidney360 study explored AKR1A1 as a potential biomarker for early DKD progression. Read more: kidney.pub/KID0966
November 21, 2025 at 6:00 PM
African Americans face high rates of diabetic kidney disease (DKD), and early detection is crucial to prevent severe kidney damage. This #ASNKidney360 study explored AKR1A1 as a potential biomarker for early DKD progression. Read more: kidney.pub/KID0966
ASN's Humanitarian Kidney Support Program (HKSP) is a coalition supporting people with kidney diseases and kidney health professionals I emergency preparedness and response, sustainability, and current and emerging threats. Read more in #ASNKidneyNews kidney.pub/KN1710-14
November 21, 2025 at 3:00 PM
ASN's Humanitarian Kidney Support Program (HKSP) is a coalition supporting people with kidney diseases and kidney health professionals I emergency preparedness and response, sustainability, and current and emerging threats. Read more in #ASNKidneyNews kidney.pub/KN1710-14
The November issue of Kidney360 is now available online! Topics covered this month include: - PD in Patients with ADPKD - Urine Microscopy for AKI - and more Check out the issue here: kidney.pub/K360-1125 #ASNK360 Cover by Husain-Syed and Harth.
November 20, 2025 at 7:00 PM
The November issue of Kidney360 is now available online! Topics covered this month include: - PD in Patients with ADPKD - Urine Microscopy for AKI - and more Check out the issue here: kidney.pub/K360-1125 #ASNK360 Cover by Husain-Syed and Harth.
Distinct analysis populations map to different causal questions. This #ASNJASN Designing Clinical Trials article dives deep into the role of analysis populations and estimands in clinical trials. Read more: kidney.pub/JASN0970
November 20, 2025 at 6:00 PM
Distinct analysis populations map to different causal questions. This #ASNJASN Designing Clinical Trials article dives deep into the role of analysis populations and estimands in clinical trials. Read more: kidney.pub/JASN0970
This study explored the role of the JAK/STAT pathway in pediatric primary focal segmental glomerulosclerosis (FSGS), a major cause of kidney disease in children. Read more: kidney.pub/KID1010
November 20, 2025 at 3:00 PM
This study explored the role of the JAK/STAT pathway in pediatric primary focal segmental glomerulosclerosis (FSGS), a major cause of kidney disease in children. Read more: kidney.pub/KID1010
Dr. Belding Scribner envisioned kidney care that enabled comprehensive rehabilitation to help restore independence and purposeful living for recipients of kidney transplants. This perspective in #ASNCJASN outlines the changes that are still needed to achieve that vision.
kidney.pub/CJASN0950
kidney.pub/CJASN0950
November 19, 2025 at 7:00 PM
Dr. Belding Scribner envisioned kidney care that enabled comprehensive rehabilitation to help restore independence and purposeful living for recipients of kidney transplants. This perspective in #ASNCJASN outlines the changes that are still needed to achieve that vision.
kidney.pub/CJASN0950
kidney.pub/CJASN0950
How does kidney function impact progression-free survival and overall survival after autologous stem cell transplantation in patients with AL amyloidosis? This #ASNKidney360 research explores: kidney.pub/KID1036
November 19, 2025 at 6:00 PM
How does kidney function impact progression-free survival and overall survival after autologous stem cell transplantation in patients with AL amyloidosis? This #ASNKidney360 research explores: kidney.pub/KID1036
Kidneys from donors who are hepatitis C virus (HCV)-viremic should remain a viable option, alleviating organ shortages, with lower than anticipated concern for cytomegalovirus complications. Read more in #ASNKidneyNews kidney.pub/KN1710-18
November 19, 2025 at 3:00 PM
Kidneys from donors who are hepatitis C virus (HCV)-viremic should remain a viable option, alleviating organ shortages, with lower than anticipated concern for cytomegalovirus complications. Read more in #ASNKidneyNews kidney.pub/KN1710-18
This #ASNKidney360 research investigates variability in eGFR and the risk of adverse kidney outcomes and all-cause mortality. Increased eGFR variability over three years independently predicted a higher risk of kidney outcomes. Read more: kidney.pub/KID0988
November 18, 2025 at 7:00 PM
This #ASNKidney360 research investigates variability in eGFR and the risk of adverse kidney outcomes and all-cause mortality. Increased eGFR variability over three years independently predicted a higher risk of kidney outcomes. Read more: kidney.pub/KID0988
Learn more about the distribution of inflammation in the kidney in #ASNJASN. This topological characterization of lymphocytic inflammation identified immune habits. Read more: kidney.pub/JASN0889
@jarcyzphd.bsky.social
@jarcyzphd.bsky.social
November 18, 2025 at 6:00 PM
Learn more about the distribution of inflammation in the kidney in #ASNJASN. This topological characterization of lymphocytic inflammation identified immune habits. Read more: kidney.pub/JASN0889
@jarcyzphd.bsky.social
@jarcyzphd.bsky.social
How do you treat nocturnal home hemodialysis? This new #ASNCJASN Kidney Case Conference discussing an under-prescribed but essential home dialysis modality in the US. Explore the case: kidney.pub/CJASN0927
November 18, 2025 at 3:00 PM
How do you treat nocturnal home hemodialysis? This new #ASNCJASN Kidney Case Conference discussing an under-prescribed but essential home dialysis modality in the US. Explore the case: kidney.pub/CJASN0927
Although international guidelines to manage CKD in patients with type 2 diabetes are available, implementation remains a challenge. In this #ASNCJASN review, authors review the literature and propose recommendations to improve: kidney.pub/CJASN0909
November 17, 2025 at 7:00 PM
Although international guidelines to manage CKD in patients with type 2 diabetes are available, implementation remains a challenge. In this #ASNCJASN review, authors review the literature and propose recommendations to improve: kidney.pub/CJASN0909
There's a lack of reliable biomarkers for non-invasive prediction of CKD in patients with diabetes, but this research in #ASNJASN presents a five-plasma protein-based algorithm for predicting incident CKD in patients with Type 2 Diabetes. Read more: kidney.pub/JASN0902 #BasicResearch
November 17, 2025 at 6:00 PM
There's a lack of reliable biomarkers for non-invasive prediction of CKD in patients with diabetes, but this research in #ASNJASN presents a five-plasma protein-based algorithm for predicting incident CKD in patients with Type 2 Diabetes. Read more: kidney.pub/JASN0902 #BasicResearch
The Glomerular Diseases Collaborative (GD-C) launched in 2024 to promote high-quality care for people living with GD. Read more about the GD-C industry roundtable, compendium, and new #ASNJASN publication in #ASNKidneyNews kidney.pub/KN1710-13
November 17, 2025 at 3:00 PM
The Glomerular Diseases Collaborative (GD-C) launched in 2024 to promote high-quality care for people living with GD. Read more about the GD-C industry roundtable, compendium, and new #ASNJASN publication in #ASNKidneyNews kidney.pub/KN1710-13
New research in #ASNJASN finds that a high phosphate and low protein combination diet induced medial artery calcification, cutaneous vascular calcification, and kidney fibrosis in mice with CKD. Read more: kidney.pub/JASN0875 #BasicResearch
November 16, 2025 at 6:00 PM
New research in #ASNJASN finds that a high phosphate and low protein combination diet induced medial artery calcification, cutaneous vascular calcification, and kidney fibrosis in mice with CKD. Read more: kidney.pub/JASN0875 #BasicResearch
New findings suggest a steady increase in the prevalence of kidney failure with replacement therapy worldwide over the past 3 decades. Read more in #ASNKidneyNews kidney.pub/KN1710-24
November 16, 2025 at 3:00 PM
New findings suggest a steady increase in the prevalence of kidney failure with replacement therapy worldwide over the past 3 decades. Read more in #ASNKidneyNews kidney.pub/KN1710-24
Should nephrologists further implement genetic testing in patients with CKD? In this #ASNJASN study of adult CKD management, genetic testing showed diagnostic and clinical utility in the year following the reporting of test results. Read more: kidney.pub/JASN0913
November 15, 2025 at 6:00 PM
Should nephrologists further implement genetic testing in patients with CKD? In this #ASNJASN study of adult CKD management, genetic testing showed diagnostic and clinical utility in the year following the reporting of test results. Read more: kidney.pub/JASN0913